(Q36827083)

English

Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer

scientific article published on November 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer (English)

1 reference

Europe PubMed Central

16 August 2017

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

W Schmiegel

1

1 reference

Europe PubMed Central

16 August 2017

J Schmielau

2

1 reference

Europe PubMed Central

16 August 2017

D Henne-Bruns

3

1 reference

Europe PubMed Central

16 August 2017

H Juhl

4

1 reference

Europe PubMed Central

16 August 2017

C Roeder

5

1 reference

Europe PubMed Central

16 August 2017

P Buggisch

6

1 reference

Europe PubMed Central

16 August 2017

A Onur

7

1 reference

Europe PubMed Central

16 August 2017

B Kremer

8

1 reference

Europe PubMed Central

16 August 2017

H Kalthoff

9

1 reference

Europe PubMed Central

16 August 2017

E V Jensen

10

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

16 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

16 August 2017

94

1 reference

Europe PubMed Central

16 August 2017

23

1 reference

Europe PubMed Central

16 August 2017

12622-12626

1 reference

Europe PubMed Central

16 August 2017

Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

Current status and future directions in the perioperative treatment of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

Collective review of small carcinomas of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

Cancer of the pancreas. 50 years of surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

The epidermal growth factor receptor in human pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

29 September 2017

Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

27 June 2018

Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

27 June 2018

Modulation of platelet-derived growth factor A- and B-chain/c-sis mRNA by tumor necrosis factor and other agents in adenocarcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

27 June 2018

A Phase II Trial of Recombinant Tumor Necrosis Factor in Patients with Adenocarcinoma of the Pancreas: A Southwest Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

27 June 2018

A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

27 June 2018

Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

27 July 2018

Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=25059

5 September 2018

Trends in pancreatic cancer mortality in Europe, 1955–1989

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.23.12622

21 January 2018

Pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.23.12622

21 January 2018

Antiproliferative effects exerted by recombinant human tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human pancreatic tumor cell lines

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.23.12622

21 January 2018

Cytolytic activity mediated by T lymphocytes

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.23.12622

21 January 2018

A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9356499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/9356499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9356499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9356499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/9356499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.94.23.12622

1 reference

Europe PubMed Central

16 August 2017

1997PNAS...9412622S

0 references

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36827083&oldid=1967253315"